Regulatory role of exogenous IL-10 in the development of immune response versus Cryptococcus neoformans

Clinical and Experimental Immunology

Volumn 109, Issue 2, 1997, Pages 242-254

  Monari, C ^a   Retini, C ^a   Palazzetti, B ^a   Bistoni, F ^a   Vecchiarelli, A ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Cryptococcus neoformans; IL 10; Monocytes

Indexed keywords

INTERLEUKIN 10;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DOWN REGULATION; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNOREGULATION; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030791083     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.4021303.x     Document Type: Article

References (27)

1. Ding L, Shevach EM. IL-10 induces mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory functions. J Immunol 1992; 148:3133-9.
2. Enk AH, Angeloni V, Udey MC, Katz SI. Inhibition of Langerhans cell antigen-presenting function by IL-10. J Immunol 1993; 151:2390-8.
3. de Waal Malefyt R, Haanen J, Spits H et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991; 174:915-22.
4. Del Prete G, De Carli F, Almerigagna F, Giudizi MG, Biagiotti R, Romagnani S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993; 150:353-60.
5. Mosmann TR, Cherwinski HM, Bond MW, Giedlin MA, Coffman RL. Two types of helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136: 2348-57.
6. Clerici M, Shearer GM. A Th1-Th2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993; 14:107-11.
7. Cohen J. T cell shift: key to AIDS therapy? Science 1993; 262:175-6.
8. Tascini C, Baldelli F, Monari C, Retini C, Pietrella D, Francisci D, Bistoni F, Vecchiarelli A. Inhibition of fungicidal activity of polymorphonuclear leukocytes from HIV-infected patients by interleukin (IL)-4 and IL-10. AIDS 1996; 10:477-83.
9. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin-10. J Exp Med 1991; 174:1549-55.
10. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes:an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174:1202-20.
11. Hidore MR, Nabavi N, Sonleitner F, Murphy JW. Murine natural killer cells are fungicidal to Cryptococcus neoformans. Infect Immun 1991; 59:1747-54.
12. Miller MF, Mitchell TG. Killing of Cryptococcus neoformans strains by human neutrophils and monocytes. Infect Immun 1991; 59:24-28.
13. Kozel TR, Mc Gaw TG. Opsonization of Cryptococcus neoformans by human immunoglobulin G:role of immunoglobulin G in phagocytosis by macrophages. Infect Immun 1979; 25:255-8.
14. L usage in polysaccharide binding antibodies. J Exp Med 1991; 174:151-60.
15. Casadevall A. Antibody immunity and invasive fungal infections. Infect Immun 1995; 63:4211-8.
16. Vecchiarelli A, Dottorini M, Pietrella D, Monari C, Retini C, Todisco T, Bistoni F. Role of human alveolar macrophages as antigen-presenting cells in Cryptococcus neoformans infection. Am J Respir Cell Mol Biol 1994; 11:130-7.
17. Vecchiarelli A, Pietrella D, Dottorini M, Monari C, Retini C, Todisco T. Encapsulation of Cryptococcus neoformans regulates fungicidal activity of the antigen presentation process in human alveolar macrophages. Clin Exp Immunol 1994; 98:217-23.
18. Vecchiarelli A, Retini C, Monari C, Tascini C, Bistoni F, Kozel TR. Purified capsular polysaccharide of C. neoformans induces IL-10 secretion by human monocytes. Infect Immun 1996; 64:2846-9.
19. Aragane Y, Riemann H, Bhardwaj RS et al. IL-12 is expressed and released by human keratinocytes and epidermoid carcinoma cell lines. J Immunol 1994; 153:5366-72.
20. Klapproth J-M, Donnenberg MS, Abraham JM, Mobley HLT, James SP. Products of enteropathogenic Escherichia coli inhibit lymphocyte activation and lymphokine production. Infect Immun 1995; 63:2248-54.
21. Chehimi J, Ma X, Chouaib S et al. Differential production of interleukin 10 during human immunodeficiency virus infection. AIDS Res Human Retrovir 1996; 12:1141-8.
22. Bogdan C, Nathan C. Modulation of macrophage function by transforming growth factor β, interleukin-4, and interleukin-10. Ann NY Acad Sci 1993; 685:713-39.
23. Oswald I, Gazzinelli RT, Sher A, James SL. IL-10 synergizes with IL-4 and transforming growth factor-β to inhibit macrophage cytotoxic activity. J Immunol 1991; 148:3578-82.
24. Mosmann TR. Properties and functions of interleukin-10. Adv Immunol 1994; 56:1-26.
25. Levitz SM, Tabuni A, Nong S-H, Golenbock DT. Effects of interleukin-10 on human peripheral blood mononuclear cell responses to Cryptococcus neoformans. Candida albicans, and lipopolysaccharide. Infect Immun 1996; 64:945-51.
26. Domer JE, Murphy JW, Deepe GS, Franco M. Immunomodulation in the mycoses. J Med Vet Mycol 1992; 30 (Suppl. 1): 157-66.
27. Maggi E, Mazzetti M, Ravina A et al. Ability of HIV to promote a Th1 to Th0 shift and to replicate preferentially in Th2 and Th0 cells. Science 1994; 265:244-8.